Russell Investments Group’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101K Sell
4,664
-442
-9% -$8.16K ﹤0.01% 3086
2025
Q4
$70.1K Buy
5,106
+619
+14% +$9.65K ﹤0.01% 3178
2025
Q3
$79.4K Buy
4,487
+1,372
+44% +$21.7K ﹤0.01% 3107
2025
Q2
$47K Buy
3,115
+333
+12% +$5.53K ﹤0.01% 2997
2025
Q1
$44.8K Sell
2,782
-46
-2% -$857 ﹤0.01% 2939
2024
Q4
$49.2K Sell
2,828
-21
-0.7% -$370 ﹤0.01% 2832
2024
Q3
$50K Sell
2,849
-28
-1% -$477 ﹤0.01% 2795
2024
Q2
$32.2K Buy
2,877
+1,530
+114% +$14.4K ﹤0.01% 2859
2024
Q1
$11.7K Sell
1,347
-56
-4% -$515 ﹤0.01% 2831
2023
Q4
$17.2K Buy
+1,403
New +$9.71K ﹤0.01% 2762

Other funds holding PLSE

Russell Investments Group's PLSE Position: Q1 2026 in Review

Russell Investments Group reduced its Pulse Biosciences (PLSE) stake by 8.7% in Q1 2026, selling an estimated $8.16K and leaving 4,664 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #3086.

Russell Investments Group first reported a position in PLSE in Q4 2023 and has held it in 10 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Russell Investments Group held 4,664 shares of Pulse Biosciences worth $101K as of Q1 2026.
  • Russell Investments Group sold 442 Pulse Biosciences shares in Q1 2026, an estimated $8.16K.
  • Pulse Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3086 holding.
  • Russell Investments Group first reported a position in Pulse Biosciences in Q4 2023 and has held it in 10 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.